CheckMyRecalls

10,013 recalls · updated 20 Nov 2026

PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls…

PAI Holdings, LLC. dba Pharmaceutical Associates Inc recalls Guaifenesin and Codeine Phosphate Oral Solution USP

Read the official FDA notice

Published
12 Feb 2025
Units affected
4080 Bottles
Agency
FDA
Country
United States

The hazard

Superpotent; sodium benzoate preservative

Classification: Class III — this product is unlikely to cause health problems but breaks FDA rules (for example labeling).

What to do

Do not stop a prescribed medicine without talking to your doctor or pharmacist first. Ask them about a replacement, and return the recalled product to the pharmacy.

  • Check the lot number on the box or bottle.
  • Talk to your pharmacist or doctor before stopping any prescribed medicine.
  • Return the product to the pharmacy for safe disposal.
Read the official FDA notice

Product details

Guaifenesin and Codeine Phosphate Oral Solution USP, 100mg/10 mg per 5 mL, 16 fl oz (473 ml) bottles, PAI Pharmaceutical Associates, Inc., Greenville, SC 29605, NDC 0121-0775-16

Brand / company
PAI Holdings, LLC. dba Pharmaceutical Associates Inc
Codes / lots
Lot number 4B07, Exp Date: 2026-OCT-31
Distribution
OH
Recall status
Terminated

Source: U.S. Food and Drug Administration, published 12 Feb 2025. CheckMyRecalls reproduces the official notice in summary; always confirm the details with the original notice.